Stockscreener 앱 받기
2.25
0.00%
0.00
시간 외 거래:
2.25
전일 마감가:
$2.25
열려 있는:
$2.26
하루 거래량:
8,605
Relative Volume:
0.87
시가총액:
$24.28M
수익:
$1.08M
순이익/손실:
$-26.95M
주가수익비율:
-0.7836
EPS:
-2.8712
순현금흐름:
$-21.69M
1주 성능:
-0.44%
1개월 성능:
-33.23%
6개월 성능:
-24.11%
1년 성능:
-46.93%
1일 변동 폭
$2.25
$2.2685
1주일 범위
$2.25
$2.4185
52주 변동 폭
$2.22
$5.96
Pluri Inc Stock (PLUR) Company Profile
명칭
Pluri Inc
전화
972-74-710-7171
주소
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Compare PLUR vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLUR
Pluri Inc
|
2.25 | 25.14M | 1.08M | -26.95M | -21.69M | -2.8712 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Pluri Inc 주식(PLUR)의 최신 뉴스
Pluri Inc. Q1 2026 Earnings: EPS Misses as Pre-Revenue Biotech Continues Pipeline DevelopmentReturn On Assets - newsline.com
Made Scientific, Pluristyx launch development and manufacturing partnership - ROI-NJ
Made Scientific and Pluristyx Launch Integrated iPSC Development & Manufacturing Partnership to Advance Next-Generation iPSC-derived Cell Therapies - The Malaysian Reserve
Pluri subsidiary completes U.S. cosmetic listing for two products By Investing.com - Investing.com Nigeria
Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing - The Manila Times
Pluri subsidiary completes U.S. cosmetic listing for two products - Investing.com
Two new skin treatments target $90B U.S. aesthetics market - Stock Titan
Pluri's Leap from Lab to Luxury: A High-Stakes Bet on Regenerative Beauty - BriefGlance
Pluri in Good-Faith Talks on EIB Loan Resolution - TipRanks
Pluri Inc. and European Investment Bank continue loan discussions, no enforcement action expected before July - Investing.com
Pluri Biotech Ltd., Pluristem Gmbh, and Pluri Inc. Remain in Constructive Discussions with European Investment Bank Regarding EUR 20 Million Loan - marketscreener.com
Pluri (NASDAQ: PLUR) negotiates with European Investment Bank over €20M loan due 2026 - Stock Titan
Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In - Insider Monkey
7 Best Lab-Grown Meat Stocks to Invest In - Insider Monkey
Pluri Inc. (PLUR) Gains 4.6%, Approaches Resistance at $2.52Breadth Thrust - The Legal Advocate
Plurilock Security Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Plurilock Security Inc.: Plurilock Security Inc. Reports First Quarter 2026 Financial Results - FinanzNachrichten.de
Pluri Insider Ups Holding During Year - Yahoo Finance
Pluri Inc. (PLUR) Posts Modest Gain as Stock Holds Above Key SupportAdaptive Moving Average - newsline.com
Pluri Inc. Q1 2026 Earnings: EPS Misses Estimates Amid Lack of Revenue DisclosureManagement Guidance Update - The Legal Advocate
Pluri Inc. (PLUR) Climbs 3.22% as Shares Test Resistance Near $2.49Community Momentum Stocks - Newser
Pluri Inc. (PLUR) Q1 2026 Earnings: Wider-than-Expected Loss Sends Shares LowerRetail Trader Picks - Newser
This Pluri Insider Increased Their Holding In The Last Year - simplywall.st
Pluri: Fiscal Q3 Earnings Snapshot - marketscreener.com
Pluri Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 - marketscreener.com
Pluri Inc. (NASDAQ: PLUR) faces going concern risk amid EIB debt wall - Stock Titan
Number of shareholders of Pluri Inc. – NASDAQ:PLUR - TradingView
PLURI INC (PLUR) Eps Diluted (TTM) - Zacks Investment Research
TradingKey - TradingKey
MSN Money - MSN
Pluri (PLUR) Earnings Date and Reports 2026 $PLUR - MarketBeat
MSN - MSN
PLUR Pluri reports wider than projected Q1 2026 loss while shares notch small gains in today’s trading session.Competitive Risk - newser.com
Insider-backed Chutzpah Holdings (NASDAQ: PLUR) buys 625K shares and warrants - Stock Titan
Weinstein group (PLUR) discloses 3.79M-share Pluri stake via CHL, CHLP, Plantae - Stock Titan
Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC) - bioinformant.com
Is Pluri (PLUR) stock cheap today | Pluri Misses EPS Estimates by 7.1% Lagging Street ViewsShared Buy Zones - newser.com
EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug - Sahm
Pluri files to sell 3.425M common shares for holders - MSN
Nasdaq Interview: Pluri CEO On Its Cell Technology And Innovation In Coffee Industry (Wsy7Unggil) - fathomjournal.org
Future Of Biotech: Pluri's 3D Cell Expansion Technology & CDMO For Global Impact | Nasdaq Interview (01igB6URuM) - fathomjournal.org
Pluri (NASDAQ: PLUR) details 2026 board elections, auditor vote and Kokomodo deal - Stock Titan
Pluri (PLUR) Profitability Outlook | Pluri posts 7.1% EPS miss, wider loss vs forecastAnalyst Stock Picks - Newser
PLUR Pluri posts 309.8 percent year over year revenue growth in Q1 2026 as quarterly EPS misses analyst estimates.Shared Buy Zones - Xã Thanh Hà
Plurilock Security Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Pluri Inc (PLUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.60%
0.94%
자본화:
|
볼륨(24시간):